Lobe Sciences Stock Today
| LOBEF Stock | USD 0 0.0003 20.00% |
Performance22 of 100
| Odds Of DistressOver 59
|
Lobe Sciences is trading at 0.0012 as of the 18th of December 2024. This is a 20 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.001. Lobe Sciences has over 59 % chance of experiencing financial distress in the next 2 years of operation, but had a somewhat solid returns during the last 90 days. The performance scores are derived for the period starting the 21st of June 2024 and ending today, the 18th of December 2024. Click here to learn more.
Lobe Sciences Ltd., a life sciences company, focuses on the research and development of psychedelic medicines. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences is traded on OTC Exchange in the United States.. The company has 76.97 M outstanding shares. More on Lobe Sciences
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Lobe OTC Stock Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Lobe Sciences [LOBEF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.01 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lobe Sciences's market, we take the total number of its shares issued and multiply it by Lobe Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lobe Sciences classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 76.97 M outstanding shares.
Lobe Sciences has accumulated about 1.38 M in cash with (2.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Lobe Sciences Probability Of Bankruptcy
Ownership AllocationLobe Sciences maintains a total of 76.97 Million outstanding shares. Roughly 97.15 % of Lobe Sciences outstanding shares are held by general public with 2.85 pct. owned by insiders and only 0.0 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Lobe Ownership Details
Lobe Sciences Risk Profiles
| Mean Deviation | 178.25 | |||
| Semi Deviation | 32.49 | |||
| Standard Deviation | 296.66 | |||
| Variance | 88007.43 |
Lobe Stock Against Markets
Picking the right benchmark for Lobe Sciences otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Lobe Sciences otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Lobe Sciences is critical whether you are bullish or bearish towards Lobe Sciences at a given time. Please also check how Lobe Sciences' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Lobe Sciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Other Information on Investing in Lobe OTC Stock
Lobe Sciences financial ratios help investors to determine whether Lobe OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lobe with respect to the benefits of owning Lobe Sciences security.